Stockreport

Moderna Refocuses On Rare Diseases As New Leadership Shapes Pipeline [Yahoo! Finance]

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF Moderna (NasdaqGS:MRNA) announced a collaboration with Recordati to develop and commercialize mRNA-3927 for propionic acidemia, a rare genetic metabolic disorder. The [Read more]